Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation

Svetlana A. Smirnikhina,Ekaterina Chelysheva,Alexander V. Lavrov,Konstantin S. Kochergin-Nikitsky,Ivan V. Mozgovoy,Elmira P. Adilgereeva,Oleg Shukhov,Anna Petrova,Anastasia Bykova,Adhamjon Abdullaev,Turkina Ag,Sergey I. Kutsev

Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation

2018

Svetlana A. Smirnikhina
Ekaterina Chelysheva
Alexander V. Lavrov
Konstantin S. Kochergin-Nikitsky
Ivan V. Mozgovoy
Elmira P. Adilgereeva
Oleg Shukhov
Anna Petrova
Anastasia Bykova
Adhamjon Abdullaev
Turkina Ag
Sergey I. Kutsev

Chronic myeloid leukemia (CML) is a myeloproliferative disease, caused by BCR/ABL protein with high tyrosine kinase activity. Since 2001, CML has been effectively treated with tyrosine kinase inhib...

Keywords:

Targeted therapy
Genetic marker
Myeloid leukemia
Discontinuation
Cancer research
Medicine
Immunology
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations